Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Avidity Partners Management LP

Avidity Partners Management LP grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 17.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,000 shares of the biopharmaceutical company’s stock after purchasing an additional 10,000 shares during the period. Regeneron Pharmaceuticals […]

Related Keywords

United States ,America ,Sanfordc Bernstein ,Leonards Schleifer , ,News Ratings For Regeneron Pharmaceuticals Daily ,Regeneron Pharmaceuticals Inc ,Quarter For Regeneron Pharmaceuticals ,Capital Management Inc ,Regeneron Pharmaceuticals Price Performance ,Morgan Stanley ,Nasdaq ,Wealth Management ,Cantor Fitzgerald ,Regeneron Pharmaceuticals ,Trinitypoint Wealth ,Securities Exchange Commission ,Eudaimonia Advisors ,Avidity Partners Management ,Free Report ,Partners Management ,Management Inc ,Point Wealth ,Exchange Commission ,Get Free Report ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,